4/30/2026

Ioversol Injection

Products Affected - Description

- Optiray 320 solution for injection, Guerbet, 100 mL bottle, 12 count, NDC 00019-1323-11
- Optiray 320 solution for injection, Guerbet, 100 mL prefilled syringe, 20 count, NDC 00019-1323-90
- Optiray 320 solution for injection, Guerbet, 125 mL prefilled syringe, 20 count, NDC 00019-1323-87
- Optiray 320 solution for injection, Guerbet, 150 mL bottle, 12 count, NDC 00019-1323-16
- Optiray 320 solution for injection, Guerbet, 200 mL bottle, 12 count, NDC 00019-1323-21
- Optiray 320 solution for injection, Guerbet, 50 mL prefilled syringe, 20 count, NDC 00019-1323-52
- Optiray 320 solution for injection, Guerbet, 50 mL vial, 25 count, NDC 00019-1323-06
- Optiray 320 solution for injection, Guerbet, 500 mL Imaging Bulk Package, bottle, 6 count, NDC 00019-1323-65
- Optiray 320 solution for injection, Guerbet, 75 mL prefilled syringe, 20 count, NDC 00019-1323-95
- Optiray 350 solution for injection, Guerbet, 100 mL bottle, 12 count, NDC 00019-1333-11
- Optiray 350 solution for injection, Guerbet, 100 mL prefilled syringe, 20 count, NDC 00019-1333-90
- Optiray 350 solution for injection, Guerbet, 125 mL prefilled syringe, 20 count, NDC 00019-1333-87
- Optiray 350 solution for injection, Guerbet, 150 mL bottle, 12 count, NDC 00019-1333-16
- Optiray 350 solution for injection, Guerbet, 200 mL bottle, 12 count, NDC 00019-1333-21
- Optiray 350 solution for injection, Guerbet, 50 mL vial, 25 count, NDC 00019-1333-06
- Optiray 350 solution for injection, Guerbet, 500 mL Imaging Bulk Package, bottle, 6 count, NDC 00019-1333-65
- Optiray 350 solution for injection, Guerbet, 75 mL prefilled syringe, 20 count, NDC 00019-1333-95

Reason for the Shortage

- Guerbet did not provide a reason for the shortage.

Available Products

- There is insufficient supply for usual ordering

Estimated Resupply Dates

- Guerbet has all Optiray-320 presentations on back order and the company cannot estimate a release date.
- Guerbet has Optiray-350 in 50 mL glass bottles and 500 mL bottles on allocation. Optiray-350 in 75 mL, 100 mL, and 125 mL power injector syringes are also on allocation. All other Optiray-350 presentations are on back order and the company cannot estimate a release date.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.